Efflux Transporter Expression and Acetaminophen Metabolite Excretion Are Altered in Rodent Models of Nonalcoholic Fatty Liver Disease

2007 ◽  
Vol 35 (10) ◽  
pp. 1970-1978 ◽  
Author(s):  
Andrew J. Lickteig ◽  
Craig D. Fisher ◽  
Lisa M. Augustine ◽  
Lauren M. Aleksunes ◽  
David G. Besselsen ◽  
...  
2020 ◽  
Vol 4 (6) ◽  
Author(s):  
Sridhar Radhakrishnan ◽  
Jia-Yu Ke ◽  
Michael A Pellizzon

ABSTRACT Nonalcoholic fatty liver disease (NAFLD) is a complex spectrum of disorders ranging from simple benign steatosis to more aggressive forms of nonalcoholic steatohepatitis (NASH) and fibrosis. Although not every patient with NAFLD/NASH develops liver complications, if left untreated it may eventually lead to cirrhosis and hepatocellular carcinoma. Purified diets formulated with specific nutritional components can drive the entire spectrum of NAFLD in rodent models. Although they may not perfectly replicate the clinical and histological features of human NAFLD, they provide a model to gain further understanding of disease progression in humans. Owing to the growing demand of diets for NAFLD research, and for our further understanding of how manipulation of dietary components can alter disease development, we outlined several commonly used dietary approaches for rodent models, including mice, rats, and hamsters, time frames required for disease development and whether other metabolic diseases commonly associated with NAFLD in humans occur.


2013 ◽  
Vol 14 (11) ◽  
pp. 21833-21857 ◽  
Author(s):  
Kento Imajo ◽  
Masato Yoneda ◽  
Takaomi Kessoku ◽  
Yuji Ogawa ◽  
Shin Maeda ◽  
...  

Digestion ◽  
2019 ◽  
Vol 101 (5) ◽  
pp. 522-535 ◽  
Author(s):  
Fang Zhong ◽  
Xiaoming Zhou ◽  
Jin Xu ◽  
Ling Gao

Nutrients ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 2871 ◽  
Author(s):  
Ines C.M. Simoes ◽  
Justyna Janikiewicz ◽  
Judith Bauer ◽  
Agnieszka Karkucinska-Wieckowska ◽  
Piotr Kalinowski ◽  
...  

Nonalcoholic fatty liver disease (NAFLD) is a common disease in Western society and ranges from steatosis to steatohepatitis to end-stage liver disease such as cirrhosis and hepatocellular carcinoma. The molecular mechanisms that are involved in the progression of steatosis to more severe liver damage in patients are not fully understood. A deeper investigation of NAFLD pathogenesis is possible due to the many different animal models developed recently. In this review, we present a comparative overview of the most common dietary NAFLD rodent models with respect to their metabolic phenotype and morphological manifestation. Moreover, we describe similarities and controversies concerning the effect of NAFLD-inducing diets on mitochondria as well as mitochondria-derived oxidative stress in the progression of NAFLD.


Sign in / Sign up

Export Citation Format

Share Document